$COPL

Copley Acquisition amended a convertible note with its sponsor, increasing funding to $900,000 for working capital. The note is interest-free and repayable at the earlier of a business combination or liquidation. The sponsor can convert amounts into units at $7.00 per unit, each including one share and a half warrant. Repayment, if no combination occurs, comes from non-trust funds. According to the company, the agreement was signed on October 6, 2026.

Copley Acquisition Corp (COPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 6, 2026, Copley Acquisition Corp (“COPL”) issued to Copley Acquisition Sponsors LLC (“Sponsor”) an amended and restated convertible promissory note (the “Note”). The Note amends and restates in its entirety that cer

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics announced a definitive business combination agreement to create a new NYSE-listed public holding company, intended to be named Ignite Proteomics Holdings, Inc. The deal is expected to close in the second half of 2026, subject to customary conditions. The companies cite a $150 million pro forma enterprise value.

Copley Acquisition Corp (COPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 copleyacq_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 BUSINESS COMBINATION AGREEMENT by and among Copley Acquisition Corp , as SPAC, Ignite Proteomics Holdings, Inc., as Pubco, Ignite Merger Sub I Inc., as SPAC Merger Sub, Ignite Merger Sub II LLC , as Company Merger Sub, Jeffrey